Zydus Lifesciences Faces USFDA Scrutiny: Six Observations at Gujarat API Unit Unveiled

Zydus Lifesciences reports six USFDA observations at its Gujarat API unit, unrelated to Data Integrity, amid a stock price decline. The company is confident in timely resolution.